iANTHUS CAPITAL HOLDINGS (ITHUF) EBT Margin (2020 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly EBT Margin came in at 21.83% in Q1 2026, down 4585.0% year-on-year from 0.49% in Q1 2025, and up 11.1% quarter-over-quarter from 24.55% in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) EBT Margin (2020 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed EBT Margin across 7 years of filings, most recently posting 21.83% for Q1 2026.
- EBT Margin for Q1 2026 came in at 21.83%, down 4585.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 28.44% (down 2447.0% YoY), and the FY2025 annual result was 16.09%, down 98.0% from the prior year.
- EBT Margin came in at 21.83% for Q1 2026 at iANTHUS CAPITAL HOLDINGS, up from 24.55% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 24.03% in Q1 2025 to a low of 846.74% in Q2 2022.
- The 5-year median for EBT Margin is 25.64% (2025), against an average of 76.81%.
- Across the five-year window, EBT Margin sank 83315 bps in 2022 and surged 81984 bps in 2023, its largest moves.
- iANTHUS CAPITAL HOLDINGS's EBT Margin stood at 126.78% in 2022, then jumped by 78 bps to 28.08% in 2023, then jumped by 43 bps to 15.94% in 2024, then slumped by 54 bps to 24.55% in 2025, then grew by 11 bps to 21.83% in 2026.
- The last three EBT Margin figures came in at 21.83% (Q1 2026), 24.55% (Q4 2025), and 25.64% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 10.97% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 33.51% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 40.73% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 25.87% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 30.30% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.35% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -156.77% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -16.70% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 41.45% |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn | -21.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.83% |
| Dec 31, 2025 | -24.55% |
| Sep 30, 2025 | -25.64% |
| Jun 30, 2025 | -41.46% |
| Mar 31, 2025 | 24.03% |
| Dec 31, 2024 | -15.94% |
| Sep 30, 2024 | -14.89% |
| Jun 30, 2024 | -6.67% |
| Mar 31, 2024 | -23.20% |
| Dec 31, 2023 | -28.08% |
| Sep 30, 2023 | -29.77% |
| Jun 30, 2023 | -26.90% |
| Mar 31, 2023 | -40.26% |
| Dec 31, 2022 | -126.78% |
| Sep 30, 2022 | -44.88% |
| Jun 30, 2022 | -846.74% |
| Mar 31, 2022 | -12.22% |
| Dec 31, 2021 | -51.29% |
| Sep 30, 2021 | -23.84% |
| Jun 30, 2021 | -13.59% |